BN Business News
Add your company to Business Communicator →

Business · 22/08/2000Updated: 10/17/2026 · 1 min read

FDA's Pregnancy Labeling Subcommittee to Meet on October 17, 2024, to Discuss Reproductive Health Drugs

Summary

The FDA's Pregnancy Labeling Subcommittee Advisory Committee for Reproductive Health Drugs will convene on October 17, 2024, to discuss and provide recommendations on labeling requirements for reproductive health drugs.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →